Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yup, that's why the shorts are going to be fighting against the longs to try and manipulate the stock price.
BrainStorm Preps for Type A NurOwn Meeting, Shakes Up C-Suite
https://www.biospace.com/article/brainstorm-preps-for-type-a-nurown-meeting-shakes-up-c-suite-for-success-/
My guess is shorters trying to freak out investors to panic sell. Looks more likely that investors will buy on the dip.
Well, since we all own the stock, and for all our sakes, I hope I'm the one that's right. ;)
If we got FDA approval, I would not be shocked if there was a news story about the big three insulin companies going into a bidding war to buy Oramed.
In 2009, Merck acquired Schering-Plough Corp in order to get their blockbuster skin cancer drug Keytruda. Merck paid 41 BILLION to buy them out. If a big company spent 41 billion to get their hands on Oramed, our stock would be worth over $1,000 per share.
Yup. If the markets didn't fall into the red today, we would still be in $13 territory.
How hard is it to get a dog to swallow a pill instead of chewing it up first?
The Global Pet Diabetes Care Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period
https://finance.yahoo.com/news/global-pet-diabetes-care-market-112200957.html
That 37% would then translate to 15.17 billion for Ketruda.
I vaguely remember reading that a Nordic company has been making Oramed's pills currently. The name escapes me though.
When the skin cancer drug Keytruda got positive phase 3 results, Merck bought the company for 41 BILLION! The insulin market is larger than the skin cancer market. If one of the big three insulin companies decided to do the same and buy Oramed for 41 billion, that would translate to a stock price of over a $1,000 per share.
It would be a gamechanger if we get confirmation from the upcoming results that Oramed's tech work. If the tech is proven to get the payload past the stomach without the strong gastric acids destroying it, then the odds go up that the same tech can safely protect a virus-based vaccine pill like covid or the flu as well.
Also, Oramed can create new revenue streams by licensing their tech to other drug companies that want to get their drugs safely past the stomach as well.
This is going to be the longest two weeks of our lives.
Check out my post on #1577. Dr. Peters brings that up.
This is why Novo's insulin pill failed:
https://www.reuters.com/article/us-novo-nordisk-insulin-pill-idUSKBN13B22I
I don't think it's a small market when 537 million people worldwide have diabetes. The IDF predicts 783 million people will have diabetes by 2045. Also, tack on the Nash & vaccine addressable markets after Oramed finishes those trials as well.
Here is that Korean deal video:
Great double-digit gain so far today. Up 12% and I'd like to see it shoot up even more and get close to $13 territory by the closing bell.
S.Korea's Medicox boosts unit for oral insulin, medical cannabis
https://www.kedglobal.com/bio-pharma/newsView/ked202212290006
That's definitely good news. Hopefully they can set up an ADCOM meeting soon after.
Positive results will be my Christmas present.
Bonus gift! We just broke through into $11 territory!
From a StockTwits post:
18 billion in revenue x modest 15% profit x 13 forward earnings = 35.1 Billion MC÷ 39.1 million shares= $897.69 per share
Yesterday, my stake was up 23.6k.
Today, my stake was up 24.8k.
I'm currently in 3-bagger territory! (+206.09%)
I FRIGGIN' CAN'T WAIT TO SEE WHAT HAPPENS TOMORROW!
Another great day today.
Hopefully, we can get a three-peat tomorrow.
I had made an educated guess awhile back about where Oramed could set the price at for their insulin pill but there are some things that I don't know yet. Like how many units of injected insulin could be replaced with one 8mg insulin pill each night? So, for example, a diabetic that normally injects 40 units of insulin per day gets an Oramed prescription and it improves their A1c level to the point that they only need to inject 20 units per day. Will Oramed set the price of each pill to the cost of 20 units of injected insulin? If yes, then the costs would be:
One pill = $6.20
30-day supply = $186.00
1-year supply = $2,263.00
If one pill can replace 40 units of insulin, then double my estimate. The reality is if Oramed gets FDA approval, they'd have 12-years of exclusivity and they can set the price anywhere they damn well want. They could set the price per pill at $10...$20...$30...possibly higher. We won't know that variable until they actually announce the price.
The day Moderna got emergency use approval for their covid vaccine, their stock price was at $18 per share. Twenty months later, it was at $449 per share.
I would not be shocked to see a similar trajectory or better.
If you were referring about how high the stock could go that day on receiving positive news, I'd use Madrigal Pharmaceuticals (MDGL) as an example. They just got positive news for their phase 3 Nash trials on Friday night. Their stock more than tripled from $63.60 to $207.80 on Monday.
Avita Medical submits FDA PMA application to expand indication for Vitiligo.
https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvSTYM4we0yheZoeFxke92GA%3D%3D
The story is behind a paywall. Can someone paste the whole story here?
Weird the link is breaking to the full Planet Microcap presentation.
Correction...when I placed the youtube link directly, it breaks the link. Embedding it by using the url button...then it works.
My guess is that the lion's share of Oramed's target market would be prediabetics and diabetics that are using medications to lower their A1c levels so that they eventually won't have to move up to injecting themselves with insulin. This was mentioned at 41 minutes into the Q&A:
If approved, I don't know if you would be prescribed to take 4 or more pills a day. As I understand it, the parameters of the phase three trial is that a clinical trial patient is either taking one 8mg pill at night. or one 8mg pill before bed and then another one at breakfast.
In the phase 2b trial, they had dose ranges from one 8mg pill all the way up to three 32mg pills per day. The 8mg pill once or twice a day had essentially the same and best scores in the trial. The other higher doses results were not as good for some reason.
So in your personal situation, maybe you would get prescribed one Oramed pill per day and you would still need to inject yourself with insulin, but just less than you currently take. I could be wrong though since I'm just guessing. It might be a good question to post on Nadav Kidron's or Dr. Anne Peter's Twitter pages.
Also, my estimate was from someone's post online. I don't know for sure if one 8mg Oramed pill will actually be the equivalent of 8 units of insulin. For all I know, one pill could end up being more than the equivalent of 8 units. We probably won't know until the January announcement at the earliest...probably later when it gets to market.
Three weeks until we get the results! Literally shaking with excitement.
Hopefully, the FDA will expedite and approve it before June of 2023.
BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration
https://seekingalpha.com/pr/19051717-brainstorm-cell-therapeutics-submits-type-meeting-request-to-u-s-food-and-drug-administration
I saw a post on a different board that estimated that one Oramed pill was the equivalent of 8 units of injectible insulin.
I was checking online at https://www.goodrx.com/healthcare-access/research/how-much-does-insulin-cost-compare-brands and the Average Retail Price of Insulin (price per insulin unit) as of October 1st, 2021 is 31¢.
If we were to extrapolate the price of an Oramed pill using that as a guide:
One pill would cost $2.48 each
A thirty day supply would cost $74.40
A year's supply for one diabetic = $905.20
1 million patients = $905 million in sales per year
10 million patients = $9 billion in sales per year
20 million patients = $18 billion in sales per year
30 million patients = $27 billion in sales per year
40 million patients = $36 billion in sales per year
50 million patients = $45 billion in sales per year
75 million patients = $67.8 billion in sales per year
100 million patients = $90.5 billion in sales per year
Saw this on the Hot Copper boards:
Quick questions:
If the FDA approves Oramed's oral insulin for sale in the United States, are there any foreign countries that use the FDA's ok as their gold standard seal of approval and will immediately approve the drug for their countries as well?
If that is the case, I'd be curious to know how many countries could potentially get access to Oramed's pill the same time as Americans do?